Find research, discussions, posts, companies, and topics.
Search uses Goglides API results from the projection-backed discovery index. Private, draft, hidden, unpublished, and admin-only content stays out of public results.
Official-source baseline for Ambev using SEC submissions, SEC company facts, the FY2025 Form 20-F, Q1 2026 Form 6-K results materials, and official peer/controller filing context.
Philip Morris generated $40.6 billion of 2025 revenue and $12.2 billion of operating cash flow, but the investment case depends on whether smoke-free growth, pricing, regulation and leverage can keep offsetting the structural decline and social risk of cigaret
NIO's June 1 delivery release showed 37,705 May deliveries and 150,526 year-to-date deliveries. The stock now turns on whether ES9, ONVO L80, and firefly can keep Q1's margin inflection alive through June.
Hershey reported FY2025 revenue of $11.7 billion, gross profit of $3.9 billion, operating income of $1.4 billion and Q1 2026 revenue of $3.1 billion. The thesis depends on cocoa-cost inflation, pricing power, brand demand, inventory control, cash conversion an
AIFU still has a large China insurance distribution platform, with 42,170 registered agents and 313 sales outlets, but the 2025 Form 20-F shows a severe revenue and asset-quality reset before a 2026 acquisition added dark tea inventory, heavy share issuance an
Agencia Comercial Spirits Ltd came public as a Taiwan whisky importer, then disclosed a 2026 AI infrastructure pivot with a non-binding US$120M server LOI, a US$14.55M PIPE, Indonesian power commitments and a five-year services agreement that may represent up
Antelope Enterprise has a Nasdaq listing, China livestream e-commerce revenue, Bitcoin financing, fresh share issuance, and a planned energy-supply launch. The catch is the filed operating base: $60.8 million of transition-period revenue produced just $131,000
Acme United looks like a sleepy tools business until the filing mix shows first aid at roughly two-thirds of sales, a new My Medic deal, tariff pain, rising debt, and a customer-concentration test.
Aurora is trying to leave the worst cannabis-stock habits behind: Q3 FY2026 medical cannabis revenue set a record, management is exiting weaker Canadian consumer lanes, and the balance sheet has cash. The catch is that IFRS losses, Bevo restructuring, internal
Albertsons has the scale, loyalty data, Own Brands, and cash flow to rebuild a standalone grocery thesis after the failed Kroger deal. The tension is whether low-margin retail, pharmacy headwinds, labor costs, debt, opioid charges, and capital returns leave en